Max Healthcare Institute : Q4 2024 Financial Quarterly Report : YoY Sales Up 17.16 %, QoQ Up 6.59 %

The comprehensive analytics outlining the performance and outlook of Max Healthcare Institute Limited”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Max Healthcare Institute Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 17.16 %. However, it did see a marginal increase of 6.59 % from the previous quarter. Expenses ticked up slightly by 9.72 % quarter-on-quarter, aligning with the annual rise of 19.13 %. Operating profit, while up 12.1 % compared to last year, faced a quarter-on-quarter dip of -1.12 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.21 %, but a shrinkage of -2.09 % sequentially. Other income fell by -1.67 % compared to the last quarter, despite an annual growth of 12.51 %. Interest expenses surged remarkably by 84.43 % from the previous quarter, yet the year-over-year increase remains at a moderate 6.14 %. Depreciation costs climbed by 15.35 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 16.52 %. Profit before tax grew annually by 11.66 % but saw a reduction from the preceding quarter by -6.66 %.
Tax expenses as a percentage of profits increased slightly by 8.53 % compared to last year, with a more notable quarter-on-quarter increase of 5.52 %. Net profit rose by 0.25 % year-on-year but witnessed a -13.06 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 0 % but a quarterly fall of -13.13 %. In summary, Max Healthcare Institute Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Max Healthcare Institute Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 17.16 % year-on-year growth, however, there was a minor increase of 6.59 % from the previous quarter. Expenses rose by 19.13 % compared to the previous year, with a 9.72 % increase quarter-on-quarter. Operating Profit surged by 12.1 % annually, and saw a -1.12 % decrease from the last quarter.
Net Profit showed yearly increase of 0.25 %, and experienced a -13.06 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 0 % annually, however dipped by -13.13 % compared to the last quarter. In essence, while Max Healthcare Institute Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.